Prothena | PRTA - Attività Correnti





Attività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Akebia Therapeutics USD 252.96M 5.38M 2025-12
ALKERMES USD 1.36B 570.52M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Exelixis USD 1.44B 41.03M 2025-12
Immunic USD 22.87M 16.4M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
MacroGenics USD 219.94M 12.15M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Prothena USD 315.19M 24.78M 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xoma USD 110.71M 5.78M 2025-09